• Home   /  
  • Archive by category "1"

Terry Rheumatoid Arthritis Case Study

1. Giles JT, Fernandes V, Lima JA, Bathon JM. Myocardial dysfunction in rheumatoid arthritis: epidemiology and pathogenesis. Arthritis Res Ther. 2005;7(5):195–207.[PMC free article][PubMed]

2. Nicola P, Maradit Kremers H, Roger V, Jacobsen S, Crowson C, Ballman K, et al. The Risk of Congestive Heart Failure in Rheumatoid Arthritis: A Population-Based Study Over 46 Years. Arthritis Rheum. 2005;52(2):412–20.[PubMed]

3. Nicola PJ, Crowson CS, Maradit-Kremers H, Ballman KV, Roger VL, Jacobsen SJ, et al. Contribution of congestive heart failure and ischemic heart disease to excess mortality in rheumatoid arthritis. Arthritis Rheum. 2006;54(1):60–7.[PubMed]

4. Jessup M, Brozena S. Heart failure. N Engl J Med. 2003;348(20):2007–18.[PubMed]

5. Mutru O, Laakso M, Isomaki H, Koota K. Cardiovascular mortality in patients with rheumatoid arthritis. Cardiology. 1989;76(1):71–7.[PubMed]

6. Wolfe F, Michaud K. Heart failure in rheumatoid arthritis: rates, predictors, and the effect of anti-tumor necrosis factor therapy. Am J Med. 2004;116:305–11.[PubMed]

7. Van Doornum S, Brand C, King B, Sundararajan V. Increased case fatality rates following a first acute cardiovascular event in patients with rheumatoid arthritis. Arthritis Rheum. 2006;54(7):2061–8.[PubMed]

8. Alpaslan M, Onrat E, Evcik D. Doppler echocardiographic evaluation of ventricular function in patients with rheumatoid arthritis. Clin Rheumatol. 2003;22(2):84–8.[PubMed]

9. Cindas A, Gokce-Kutsal Y, Tokgozoglu L, Karanfil A. QT dispersion and cardiac involvement in patients with rheumatoid arthritis. Scand J Rheumatol. 2002;31(1):22–6.[PubMed]

10. Corrao S, Salli L, Arnone S, Scaglione R, Pinto A, Licata G. Echo-Doppler left ventricular filling abnormalities in patients with rheumatoid arthritis without clinically evident cardiovascular disease. Eur J Clin Invest. 1996;26(4):293–7.[PubMed]

11. Dawson JK, Goodson NG, Graham DR, Lynch MP. Raised pulmonary artery pressures measured with Doppler echocardiography in rheumatoid arthritis patients. Rheumatology. 2000;39(12):1320–5.[PubMed]

12. Di Franco M, Paradiso M, Mammarella A, Paoletti V, Labbadia G, Coppotelli L, et al. Diastolic function abnormalities in rheumatoid arthritis. Evaluation By echo Doppler transmitral flow and pulmonary venous flow: relation with duration of disease. Ann Rheum Dis. 2000;59(3):227–9.[PMC free article][PubMed]

13. Gonzalez-Juanatey C, Testa A, Garcia-Castelo A, Garcia-Porrua C, Llorca J, Ollier WE, et al. Echocardiographic and Doppler findings in long-term treated rheumatoid arthritis patients without clinically evident cardiovascular disease. Semin Arthritis Rheum. 2004;33(4):231–8.[PubMed]

14. Levendoglu F, Temizhan A, Ugurlu H, Ozdemir A, Yazici M. Ventricular function abnormalities in active rheumatoid arthritis: a Doppler echocardiographic study. Rheumatol Int. 2004;24(3):141–6.[PubMed]

15. Montecucco C, Gobbi G, Perlini S, Rossi S, Grandi AM, Caporali R, et al. Impaired diastolic function in active rheumatoid arthritis. Relationship with disease duration. Clin Exp Rheumatol. 1999;17(4):407–12.[PubMed]

16. Mustonen J, Laakso M, Hirvonen T, Mutru O, Pirnes M, Vainio P, et al. Abnormalities in left ventricular diastolic function in male patients with rheumatoid arthritis without clinically evident cardiovascular disease. Eur J Clin Invest. 1993;23(4):246–53.[PubMed]

17. Wislowska M, Sypula S, Kowalik I. Echocardiographic findings and 24-h electrocardiographic Holter monitoring in patients with nodular and non-nodular rheumatoid arthritis. Rheumatol Int. 1999;18(5-6):163–9.[PubMed]

18. Maradit Kremers H, Crowson CS, Gabriel SE. Rochester Epidemiology Project: a unique resource for research in the rheumatic diseases. Rheum Dis Clin North Am. 2004;30(4):819–34. vii. [PubMed]

19. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988;31(3):315–24.[PubMed]

20. From AM, Leibson CL, Bursi F, Redfield MM, Weston SA, Jacobsen SJ, et al. Diabetes in heart failure: prevalence and impact on outcome in the population. Am J Med. 2006;119(7):591–9.[PubMed]

21. Roger VL, Weston SA, Redfield MM, Hellermann-Homan JP, Killian J, Yawn BP, et al. Trends in heart failure incidence and survival in a community-based population. JAMA. 2004;292(3):344–50.[PubMed]

22. Ho KK, Pinsky JL, Kannel WB, Levy D. The epidemiology of heart failure: the Framingham Study. Journal of the American College of Cardiology. 1993;22(4 Suppl A):6A–13A.[PubMed]

23. Alberti K, Zimmet P. Definition, diagnosis and classification of diabetes mellitus and its complications. I. Diagnosis and classification of diabetes mellitus provisional report of a WHO consultations. Diabet Med. 1998;15:539–53.[PubMed]

24. Patel JB, Borgeson DD, Barnes ME, Rihal CS, Daly RC, Redfield MM. Mitral regurgitation in patients with advanced systolic heart failure. J Card Fail. 2004;10(4):285–91.[PubMed]

25. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, et al. Recommendations for chamber quantification: a report from the American Society of Echocardiography’s Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr. 2005;18(12):1440–63.[PubMed]

26. Yturralde RF, Gaasch WH. Diagnostic criteria for diastolic heart failure. Prog Cardiovasc Dis. 2005;47(5):314–9.[PubMed]

27. Gaasch WH, Zile MR. Left ventricular diastolic dysfunction and diastolic heart failure. Annu Rev Med. 2004;55:373–94.[PubMed]

28. Zile MR, Baicu CF, Gaasch WH. Diastolic heart failure--abnormalities in active relaxation and passive stiffness of the left ventricle. N Engl J Med. 2004;350(19):1953–9.[PubMed]

29. Zile MR, Gaasch WH, Carroll JD, Feldman MD, Aurigemma GP, Schaer GL, et al. Heart failure with a normal ejection fraction: is measurement of diastolic function necessary to make the diagnosis of diastolic heart failure? Circulation. 2001;104(7):779–82.[PubMed]

30. Aurigemma GP, Zile MR, Gaasch WH. Lack of relationship between Doppler indices of diastolic function and left ventricular pressure transients in patients with definite diastolic heart failure. Am Heart J. 2004;148(3):E12.[PubMed]

31. Corrao S, Salli L, Arnone S, Scaglione R, Pinto A, Licata G. Echo-Doppler left ventricular filling abnormalities in patients with rheumatoid arthritis without clinically evident cardiovascular disease. Euro J Clin Invest. 1996;26(4):293–7.[PubMed]

32. Di Franco M, Paradiso M, Mammarella A, Paoletti V, Labbadia G, Coppotelli L, et al. Diastolic function abnormalities in rheumatoid arthritis. Evaluation By echo Doppler transmitral flow and pulmonary venous flow: relation with duration of disease. Annals of the Rheumatic Diseases. 2000;59(3):227–9.[PMC free article][PubMed]

33. Mustonen J, Laakso M, Hirvonen T, Mutru O, Pirnes M, Vainio P, et al. Abnormalities in left ventricular diastolic function in male patients with rheumatoid arthritis without clinically evident cardiovascular disease. Euro J Clin Invest. 1993;23(4):246–53.[PubMed]

34. Wislowska M, Sypula S, Kowalik I. Echocardiographic findings, 24-hour electrocardiographic Holter monitoring in patients with rheumatoid arthritis according to Steinbrocker’s criteria, functional index, value of Waaler-Rose titre and duration of disease. Clin Rheumatol. 1998;17(5):369–77.[PubMed]

35. Crowson CS, Nicola PJ, Kremers HM, O’Fallon WM, Therneau TM, Jacobsen SJ, et al. How much of the increased incidence of heart failure in rheumatoid arthritis is attributable to traditional cardiovascular risk factors and ischemic heart disease? Arthritis Rheum. 2005;52(10):3039–44.[PubMed]

36. Maradit Kremers H, Nicola P, Crowson C, Ballman K, Gabriel S. Prognostic Importance of Low Body Mass Index (BMI) in Relation to Cardiovascular Mortality in Rheumatoid Arthritis. Arthritis & Rheumatism. 2004;50(11):3450–3457.[PubMed]

37. Owan TE, Hodge DO, Herges RM, Jacobsen SJ, Roger VL, Redfield MM. Trends in prevalence and outcome of heart failure with preserved ejection fraction. N Engl J Med. 2006;355(3):251–9.[PubMed]

38. Yndestad A, Damas JK, Oie E, Ueland T, Gullestad L, Aukrust P. Role of inflammation in the progression of heart failure. Curr Cardiol Rep. 2007;9(3):236–41.[PubMed]

39. Hunt SA, Abraham WT, Chin MH, Feldman AM, Francis GS, Ganiats TG, et al. ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society. Circulation. 2005;112(12):e154–235.[PubMed]

40. Aurigemma GP, Gottdiener JS, Shemanski L, Gardin J, Kitzman D. Predictive value of systolic and diastolic function for incident congestive heart failure in the elderly: the cardiovascular health study. J Am Coll Cardiol. 2001;37(4):1042–8.[PubMed]

41. Redfield MM, Jacobsen SJ, Burnett JC, Jr., Mahoney DW, Bailey KR, Rodeheffer RJ. Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic. JAMA. 2003;289(2):194–202.[PubMed]

42. Wei L, MacDonald T, Walker B. Taking glucocorticoids by prescription is associated with subsequent cardiovascular disease. Annals of Internal Medicine. 2004;141:764–770.[PubMed]

43. Souverein PC, Berard A, Van Staa TP, Cooper C, Egberts ACG, Leufkens HGM, et al. Use of oral glucocorticoids and risk of cardiovascular and cerebrovascular disease in a population based case-control study. Heart. 2004;90:859–65.[PMC free article][PubMed]

44. Mamdani M, Juurlink DN, Lee DS, Rochon PA, Kopp A, Naglie G, et al. Cyclo-oxygenase-2 inhibitors versus non-selective non-steroidal anti-inflammatory drugs and congestive heart failure outcomes in elderly patients: a population-based cohort study. Lancet. 2004;363(9423):1751–6.[PubMed]

45. Feenstra J, Heerdink ER, Grobbee DE, Stricker BH. Association of nonsteroidal anti-inflammatory drugs with first occurrence of heart failure and with relapsing heart failure: the Rotterdam Study. Arch Intern Med. 2002;162(3):265–70.[PubMed]

46. Davis JM, 3rd, Maradit Kremers H, Crowson CS, Nicola PJ, Ballman KV, Therneau TM, et al. Glucocorticoids and cardiovascular events in rheumatoid arthritis: a population-based cohort study. Arthritis Rheum. 2007;56(3):820–30.[PubMed]

  • 1.

    Borchers AT, Selmi C, Cheema G, Keen CL, Shoenfeld Y, Gershwin ME (2006) Juvenile idiopathic arthritis. Autoimmun Rev 5:279–298PubMedCrossRefGoogle Scholar

  • 2.

    Taylor J, Erlandson D (2001) Pediatric rheumatic diseases. In: Clinical care of the rheumatic diseases. American College of Rheumatology, Atlanta, GAGoogle Scholar

  • 3.

    Gare A (1999) Juvenile arthritis—who gets it, where and when? A review of current data on incidence and prevalence. Clin Exp Rheumatol 17:367–374Google Scholar

  • 4.

    Towner SR, Michet CJ Jr, O'Fallon WM, Nelson AM (1983) The epidemiology of juvenile arthritis in Rochester, Minnesota 1960–1979. Arthritis Rheum 26:1208–1213PubMedCrossRefGoogle Scholar

  • 5.

    Henderson CJ, Cackwell GD, Specker BL, Sierra RI, Wilmott RW, Campaigne BN, Lovell DJ (1997) Predictors of total body bone mineral density in non-corticosteroid-treated prepubertal children with juvenile rheumatoid arthritis. Arthritis Rheum 40:1967–1975PubMedCrossRefGoogle Scholar

  • 6.

    Kotaniemi K, Aho K, Kotaniemi A (2001) Uveitis as a cause of visual loss in arthritides and comparable conditions. J Rheumatol 28:309–312PubMedGoogle Scholar

  • 7.

    Sawyer MG, Whitham JN, Roberton DM, Taplin JE, Varni JW, Baghurst PA (2004) The relationship between health-related quality of life, pain and coping strategies in juvenile idiopathic arthritis. Rheumatology (Oxford) 43:325–330CrossRefGoogle Scholar

  • 8.

    Welbury RR, Thomason JM, Fitzgerald JL, Steen IN, Marshall NJ, Foster HE (2003) Increased prevalence of dental caries and poor oral hygiene in juvenile idiopathic arthritis. Rheumatology (Oxford) 42:1445–1451CrossRefGoogle Scholar

  • 9.

    Feige U, Karbowski A, Rordorf-Adam C, Pataki A (1989) Arthritis induced by continuous infusion of hr-interleukin-1 alpha into the rabbit knee-joint. Int J Tissue React 11:225–238PubMedGoogle Scholar

  • 10.

    Fontana A, Hengartner H, Weber E, Fehr K, Grob PJ, Cohen G (1982) Interleukin 1 activity in the synovial fluid of patients with rheumatoid arthritis. Rheumatol Int 2:49–53PubMedCrossRefGoogle Scholar

  • 11.

    Saxena N, Aggarwal A, Misra R (2005) Elevated concentrations of monocyte derived cytokines in synovial fluid of children with enthesitis related arthritis and polyarticular types of juvenile idiopathic arthritis. J Rheumatol 32:1349–1353PubMedGoogle Scholar

  • 12.

    Havemose-Poulsen A, Sorensen LK, Bendtzen K, Holmstrup P (2007) Polymorphisms within the IL-1 gene cluster: effects on cytokine profiles in peripheral blood and whole blood cell cultures of patients with aggressive periodontitis, juvenile idiopathic arthritis, and rheumatoid arthritis. J Periodontol 78:475–492PubMedCrossRefGoogle Scholar

  • 13.

    Kutukculer N, Caglayan S, Aydogdu F (1998) Study of pro-inflammatory (TNF-alpha, IL-1alpha, IL-6) and T-cell-derived (IL-2, IL-4) cytokines in plasma and synovial fluid of patients with juvenile chronic arthritis: correlations with clinical and laboratory parameters. Clin Rheumatol 17:288–292PubMedCrossRefGoogle Scholar

  • 14.

    Madson KL, Moore TL, Lawrence JM 3rd, Osborn TG (1994) Cytokine levels in serum and synovial fluid of patients with juvenile rheumatoid arthritis. J Rheumatol 21:2359–2363PubMedGoogle Scholar

  • 15.

    Geiger T, Towbin H, Cosenti-Vargas A, Zingel O, Arnold J, Rordorf C, Glatt M, Vosbeck K (1993) Neutralization of interleukin-1 beta activity in vivo with a monoclonal antibody alleviates collagen-induced arthritis in DBA/1 mice and prevents the associated acute-phase response. Clin Exp Rheumatol 11:515–522PubMedGoogle Scholar

  • 16.

    Cohen S, Hurd E, Cush J, Schiff M, Weinblatt ME, Moreland LW, Kremer J, Bear MB, Rich WJ, McCabe D (2002) Treatment of rheumatoid arthritis with anakinra, a recombinant human interleukin-1 receptor antagonist, in combination with methotrexate: results of a twenty-four-week, multicenter, randomized, double-blind, placebo-controlled trial. Arthritis Rheum 46:614–624PubMedCrossRefGoogle Scholar

  • 17.

    Cohen SB, Moreland LW, Cush JJ, Greenwald MW, Block S, Shergy WJ, Hanrahan PS, Kraishi MM, Patel A, Sun G, Bear MB (2004) A multicentre, double blind, randomised, placebo controlled trial of anakinra (Kineret), a recombinant interleukin 1 receptor antagonist, in patients with rheumatoid arthritis treated with background methotrexate. Ann Rheum Dis 63:1062–1068PubMedCrossRefGoogle Scholar

  • 18.

    Nuki G, Bresnihan B, Bear MB, McCabe D (2002) Long-term safety and maintenance of clinical improvement following treatment with anakinra (recombinant human interleukin-1 receptor antagonist) in patients with rheumatoid arthritis: extension phase of a randomized, double-blind, placebo-controlled trial. Arthritis Rheum 46:2838–2846PubMedCrossRefGoogle Scholar

  • 19.

    Irigoyen P, Olson J, Hom C, Ilowite NT (2004) Treatment of systemic onset juvenile rheumatoid arthritis with anakinra [abstract]. Arthritis Rheum 50(suppl):S437–438Google Scholar

  • 20.

    Pascual V, Allantaz F, Arce E, Punaro M, Banchereau J (2005) Role of interleukin-1 (IL-1) in the pathogenesis of systemic onset juvenile idiopathic arthritis and clinical response to IL-1 blockade. J Exp Med 201:1479–1486PubMedCrossRefGoogle Scholar

  • 21.

    Johnson CJ, Reilly KM, Murray KM (2001) Etanercept in juvenile rheumatoid arthritis. Ann Pharmacother 35:464–471PubMedCrossRefGoogle Scholar

  • 22.

    Giannini EH, Ruperto N, Ravelli A, Lovell DJ, Felson DT, Martini A (1997) Preliminary definition of improvement in juvenile arthritis. Arthritis Rheum 40:1202–1209PubMedGoogle Scholar

  • 23.

    Yang B, Frazier J, McCabe J, Young J (2000) Population pharmacokinetics of recombinant interleukin-1 receptor antagonist (anakinra) in subjects with rheumatoid arthritis (RA) [abstract]. Arthritis Rheum 43(suppl):S153Google Scholar

  • 24.

    Yang B, Frazier J, McCabe J, Young J (2001) Population pharmacokinetics (PK) of anakinra in subjects with rheumatoid arthritis RA [abstract]. Ann Rheum Dis 60(suppl 1):161Google Scholar

  • 25.

    Bresnihan B (2001) The safety and efficacy of interleukin-1 receptor antagonist in the treatment of rheumatoid arthritis. Semin Arthritis Rheum 30:17–20PubMedCrossRefGoogle Scholar

  • 26.

    WHO (World Health Organization) Toxicity Criteria (2008) Available via http://www.fda.gov/cder/cancer/toxicityframe.htm. Cited February 6, 2008

  • 27.

    Fleischmann RM, Tesser J, Schiff MH, Schechtman J, Burmester GR, Bennett R, Modafferi D, Zhou L, Bell D, Appleton B (2006) Safety of extended treatment with anakinra in patients with rheumatoid arthritis. Ann Rheum Dis 65:1006–1012PubMedCrossRefGoogle Scholar

  • 28.

    Shaw KL, Southwood TR, Duffy CM, McDonagh JE (2006) Health-related quality of life in adolescents with juvenile idiopathic arthritis. Arthritis Rheum 55:199–207PubMedCrossRefGoogle Scholar

  • 29.

    Doran MF, Crowson CS, Pond GR, O'Fallon WM, Gabriel SE (2002) Frequency of infection in patients with rheumatoid arthritis compared with controls: a population-based study. Arthritis Rheum 46:2287–2293PubMedCrossRefGoogle Scholar

  • 30.

    Listing J, Strangfeld A, Kary S, Rau R, von Hinueber U, Stoyanova-Scholz M, Gromnica-Ihle E, Antoni C, Herzer P, Kekow J, Schneider M, Zink A (2005) Infections in patients with rheumatoid arthritis treated with biologic agents. Arthritis Rheum 52:3403–3412PubMedCrossRefGoogle Scholar

  • 31.

  • One thought on “Terry Rheumatoid Arthritis Case Study

    Leave a comment

    L'indirizzo email non verrà pubblicato. I campi obbligatori sono contrassegnati *